Tag: parp inhibitor

#VisualAbstract Oral poly(ADP-ribose) polymerase inhibitors were associated with an increased risk of myelodysplastic syndrome and acute myeloid leukaemia over placebo treatment in patients with cancer

byKathleen Lau

January 22, 2021

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Extended aromatase inhibitor therapy reduces breast cancer recurrence in postmenopausal women
GSK and Hengrui Pharma Forge $500 Million China Collaboration
#VisualAbstract: Ciprofloxacin is Noninferior to Aminoglycoside–Ciprofloxacin for Treatment of Bubonic Plague

No Result

View All Result